Search

everythinglearnresearchcommunity

for

Search:↓

Parents of women with PCOS have a higher risk of Type II diabetes and insulin resistance, especially fathers.

Activating the Wnt/β-catenin pathway could lead to new hair loss treatments.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Vitiligo affects overall health and self-esteem, needing more research and awareness.

The document concludes that various clinical methods are used to assess ageing skin and the effectiveness of anti-ageing products.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Fibroblasts can be turned into melanocytes for potential skin treatments.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Wnt1a-conditioned medium from stem cells helps activate cells important for hair growth and can promote hair regrowth.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Eating healthy, exercising, and taking certain supplements can help manage Polycystic Ovary Syndrome symptoms.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Assessing newborn scalp hair can reveal important health information.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

CYLD mutations cause a variety of skin tumors with symptoms starting around age 16, and treatments are currently limited.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

The nutritional supplement improved hair density and reduced hair loss in women with female pattern hair loss.